…
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 2800.00M | 5248.00M | 1617.00M | 1344.00M | 1888.00M |
| Minority interest | -960.00M | -864.00M | -660.00M | -590.00M | -562.00M |
| Net income | 1407.00M | 3200.00M | 611.00M | 1000.00M | 1477.00M |
| Selling general administrative | 8705.00M | 8801.00M | 9146.00M | 8844.00M | 8878.00M |
| Selling and marketing expenses | - | 2893.00M | 8728.00M | - | - |
| Gross profit | 17530.00M | 8209.00M | 7805.00M | 15901.00M | 16157.00M |
| Reconciled depreciation | 863.00M | 818.00M | 867.00M | 841.00M | 855.00M |
| Ebit | 3621.00M | 6074.00M | 2518.00M | 2333.00M | 2871.00M |
| Ebitda | 4484.00M | 6892.00M | 3388.00M | 3479.00M | 3496.00M |
| Depreciation and amortization | 863.00M | 818.00M | 870.00M | 1146.00M | 625.00M |
| Non operating income net other | - | - | - | -99.00M | -60.00M |
| Operating income | 3439.00M | 5956.00M | 2510.00M | 2333.00M | 2871.00M |
| Other operating expenses | 17871.00M | 14709.00M | 18038.00M | 16762.00M | 17076.00M |
| Interest expense | 821.00M | 826.00M | 901.00M | 890.00M | 923.00M |
| Tax provision | 433.00M | 1184.00M | 290.00M | 344.00M | 411.00M |
| Interest income | 821.00M | 826.00M | 901.00M | 890.00M | 923.00M |
| Net interest income | -821.00M | -826.00M | -893.00M | -890.00M | -923.00M |
| Extraordinary items | - | - | 0.00M | 1.00M | -1.00M |
| Non recurring | - | - | - | 70.00M | 116.00M |
| Income tax expense | 433.00M | 1184.00M | 306.00M | 344.00M | 411.00M |
| Total revenue | 21310.00M | 20665.00M | 20548.00M | 19174.00M | 19485.00M |
| Total operating expenses | 14091.00M | 2253.00M | 5295.00M | 13489.00M | 13748.00M |
| Cost of revenue | 3780.00M | 12456.00M | 12743.00M | 3273.00M | 3328.00M |
| Total other income expense net | -639.00M | -708.00M | -893.00M | -989.00M | -983.00M |
| Discontinued operations | - | - | - | 1.00M | -1.00M |
| Net income from continuing ops | 2367.00M | 4064.00M | 1129.00M | 1000.00M | 1477.00M |
| Net income applicable to common shares | 1407.00M | 3200.00M | 611.00M | 411.00M | 914.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 29677.00M | 28936.00M | 28312.00M | 27156.00M | 27579.00M |
| Intangible assets | 1348.00M | 1397.00M | 1368.00M | 1424.00M | 1497.00M |
| Other current assets | 2053.00M | 1263.00M | 2124.00M | 1775.00M | 1557.00M |
| Total liab | 20704.00M | 20389.00M | 22804.00M | 22548.00M | 23322.00M |
| Total stockholder equity | 4220.00M | 4171.00M | 1608.00M | 1142.00M | 1028.00M |
| Deferred long term liab | - | - | - | 217.00M | 36.00M |
| Other current liab | 3024.00M | 2702.00M | 3209.00M | 2717.00M | 2715.00M |
| Common stock | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
| Capital stock | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
| Retained earnings | 4415.00M | 3008.00M | -192.00M | -803.00M | -1214.00M |
| Other liab | - | - | - | 2092.00M | 2702.00M |
| Good will | 11198.00M | 10691.00M | 10307.00M | 10123.00M | 9261.00M |
| Other assets | 84.00M | 128.00M | 120.00M | 19.00M | 65.00M |
| Cash | 2883.00M | 3019.00M | 1228.00M | 858.00M | 2364.00M |
| Cash and equivalents | 2883.00M | 3019.00M | 1228.00M | 858.00M | 2364.00M |
| Total current liabilities | 4463.00M | 4310.00M | 4760.00M | 4476.00M | 5109.00M |
| Current deferred revenue | - | - | 59.00M | 110.00M | 959.00M |
| Net debt | 10288.00M | 11308.00M | 13774.00M | 14221.00M | 13282.00M |
| Short term debt | 79.00M | 296.00M | 120.00M | 145.00M | 135.00M |
| Short long term debt | 79.00M | 92.00M | 120.00M | 145.00M | 135.00M |
| Short long term debt total | 13171.00M | 14327.00M | 15002.00M | 15079.00M | 15646.00M |
| Other stockholder equity | -22.00M | 1335.00M | 1973.00M | 2118.00M | 2467.00M |
| Property plant equipment | 6315.00M | 7086.00M | 7319.00M | 6462.00M | 6427.00M |
| Total current assets | 7849.00M | 7682.00M | 7167.00M | 5981.00M | 7075.00M |
| Long term investments | 1442.00M | 1532.00M | 1560.00M | 3147.00M | 3254.00M |
| Net tangible assets | - | - | - | -8256.00M | -9730.00M |
| Short term investments | - | 1505.00M | - | -1518.00M | -1439.00M |
| Net receivables | 2565.00M | 3054.00M | 3404.00M | 2943.00M | 2770.00M |
| Long term debt | 13092.00M | 13081.00M | 14882.00M | 14934.00M | 15511.00M |
| Inventory | 348.00M | 346.00M | 411.00M | 405.00M | 384.00M |
| Accounts payable | 1360.00M | 1294.00M | 1408.00M | 1504.00M | 1300.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 1317.00M | 1026.00M |
| Accumulated other comprehensive income | -181.00M | -180.00M | -181.00M | -181.00M | -233.00M |
| Common stock total equity | - | - | - | 8.00M | 8.00M |
| Retained earnings total equity | - | - | - | -803.00M | -1214.00M |
| Treasury stock | - | - | - | - | -2410.00M |
| Non currrent assets other | 307.00M | 194.00M | 180.00M | 389.00M | 317.00M |
| Non current assets total | 21828.00M | 21254.00M | 21145.00M | 21175.00M | 20504.00M |
| Long term debt total | 13092.00M | 13081.00M | 14882.00M | 14934.00M | 15511.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 3.00M | 3429.00M | -942.00M | -808.00M | -714.00M |
| Change to liabilities | - | - | - | -913.00M | -584.00M |
| Total cashflows from investing activities | -1275.00M | 3429.00M | -969.00M | -808.00M | -714.00M |
| Net borrowings | -96.00M | -2220.00M | -172.00M | -852.00M | -349.00M |
| Total cash from financing activities | -2401.00M | -3685.00M | -1035.00M | -1781.00M | -936.00M |
| Change to operating activities | - | - | - | -15.00M | 28.00M |
| Net income | 1407.00M | 4064.00M | 1311.00M | 1001.00M | 1476.00M |
| Change in cash | -136.00M | 1791.00M | 370.00M | -1506.00M | -82.00M |
| Begin period cash flow | 3019.00M | 1228.00M | 858.00M | 2364.00M | 2446.00M |
| End period cash flow | 2883.00M | 3019.00M | 1228.00M | 858.00M | 2364.00M |
| Total cash from operating activities | 3540.00M | 2047.00M | 2374.00M | 1083.00M | 1568.00M |
| Depreciation | 886.00M | 818.00M | 870.00M | 841.00M | 855.00M |
| Other cashflows from investing activities | 40.00M | 4962.00M | 60.00M | -46.00M | -7.00M |
| Dividends paid | - | - | - | 560.00M | 423.00M |
| Change to inventory | -73.00M | -86.00M | -139.00M | -64.00M | -52.00M |
| Change to account receivables | 20.00M | 245.00M | -29.00M | -140.00M | -197.00M |
| Sale purchase of stock | -1437.00M | -672.00M | -200.00M | -250.00M | -2.00M |
| Other cashflows from financing activities | -868.00M | -793.00M | -663.00M | 1320.00M | 2285.00M |
| Change to netincome | - | - | - | 341.00M | 503.00M |
| Capital expenditures | 1010.00M | 931.00M | 751.00M | 762.00M | 658.00M |
| Change receivables | - | - | - | -140.00M | -197.00M |
| Cash flows other operating | - | - | - | -80.00M | -496.00M |
| Cash and cash equivalents changes | - | - | - | -1506.00M | -82.00M |
| Change in working capital | -44.00M | 136.00M | 71.00M | -1143.00M | -737.00M |
| Stock based compensation | 104.00M | 67.00M | 66.00M | 56.00M | 56.00M |
| Other non cash items | 1187.00M | -2935.00M | 4.00M | 119.00M | -332.00M |
| Free cash flow | 2530.00M | 1116.00M | 1623.00M | 321.00M | 910.00M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare Corporation |
-9.29 3.18% |
282.96 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| HCA HCA Healthcare, Inc. |
-7.21 1.41% |
503.49 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.09 0.62% |
14.50 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
4.81 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
| FMCQF Fresenius Medical Care AG & Co. KGaA |
- -% |
43.82 | 14.21 | 9.00 | 0.78 | 0.77 | 0.98 | 5.67 |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
14201 Dallas Parkway, Dallas, TX, United States, 75254
469 893 2200
77000
| Name | Title | Year Born |
|---|---|---|
| Dr. Saumya Sutaria M.D. | Pres, CEO, COO & Director | 1973 |
| Mr. Daniel J. Cancelmi | CFO & Exec. VP | 1963 |
| Ms. Paola M. Arbour | Exec. VP & Chief Information Officer | 1964 |
| Mr. Thomas W. Arnst | EVP, Chief Admin. Officer, Chief Risk Officer, Gen. Counsel & Corp. Sec. | 1963 |
| Mr. William McDowell III | VP of Investor Relations | NA |
| Ms. Jana Durfee | Sr. VP & Chief Compliance Officer | NA |
| Ms. Marie Quintana | Exec. VP of Communications & Chief Marketing Officer | 1957 |
| Mr. Michael T. Maloney | Exec. VP of Corp. Devel. | NA |
| Mr. Bill Durham | Chief Financial Officer of Nola Regional Health Network | NA |
| Mr. Clint Hailey | Chief Managed Care Officer & Sr. VP | 1965 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.